InvestmentOntarioResearch & DevelopmentStart a Business

Life Sciences Innovation Fund (LSIF)

Ontario’s Life Sciences Innovation Fund (LSIF) is an early-stage co-investment fund that supports companies in Life Sciences and Healthcare Technologies sectors related to human health.

Through the fund, OCI co-invests with angel and other investors to help de-risk the opportunity, assisting start-ups in becoming investor and customer ready and allowing them to attract follow-on investment.

Offered by Ontario Centre of Innovation (oci)

Amount

Up to $500,000

Up to $500,000 in early stage risk capital per eligible company, co-invested by OCI with angel and other investors

Quick eligibility check

Years in business
Up to 5 years
Employees
No limit stated
Revenue
No limit stated
Legal structure
Incorporated
Location
Ontario

Who can apply

SECTORS FUNDING GEOGRAPHY STAGE

Human Health-related Life Investment up to $500K at Companies that are Investing in early-stage Sciences with a minimum the pre-seed and seed headquartered and company with competitive IP addressable market size of stages. predominantly located from the conceptual stage within the Province of $100M. through commercialization Ontario.

Current company headcount must be >50% located in Ontario (not projected).

Looking for Start-ups that

(Eligibility Criteria):

Looking for • Incorporated for no more than five years (Ontario or Canadian for-profit incorporation) and have principal operations in Start-ups that Ontario.

(Eligibility Criteria):

  1. Have raised less than $3 million from third-party capital.
  2. Seeking to raise Pre-Seed and Seed investments (total round

sizes range from $1 to $5 million).

  1. Ontario-based accredited investors should be part of the

investment round.

Not eligible:

Note: OCI Ready for Market (R4M) Portfolio companies are not eligible for investment via the Life Sciences Innovation Fund (LSIF

About the funding

Through the fund, OCI co-invests with angel and other investors to help de-risk the opportunity, assisting start-ups in becoming investor and customer ready and allowing them to attract follow-on investment.

Eligible companies will receive up to $500,000 in early stage risk capital to scale their made-in-Ontario health solution both at home and in global markets.

For details on the OCI lifetime funding limit, please refer to– https://www.oc-innovation.ca/programs.

Businesses funded by this program

20 businesses funded since 2021

10 most recent recipients

BusinessLocationYear
Bao Life Brand Inc. (aka BAO Laboratory)Markham, ON2025
Gene42 Inc. (dba PhenoTips)Toronto, ON2025
12223392 Canada Inc. (dba Clincove Inc.)Ottawa, ON2025
Orb Therapeutics Inc.Toronto, ON2025
Grey Matter Neurosciences IncorporatedToronto, ON2024
We Are Marlow CorporationToronto, ON2024
HDAX Therapeutics Inc.Mississauga, ON2024
Cohesys Inc.Toronto, ON2024
KVR PHARMACEUTICALS INC.Burlington, ON2024
Noa Therapeutics Inc.Toronto, ON2023

Source: Ontario Centre of Innovation, projects.

Similar programs

ProgramTypeAmountStatus
Ready 4 Market (R4M) FundInvestmentCo-investment with angel and other investors of up to $250,000 per companyOpen
BDC Growth Equity PartnersInvestmentEquity investments from $3M to $45M, acquiring ownership stakes up to 49%, for growth capital or an ownership transitionOpen
BDC Growth Venture FundInvestmentNo fixed amountOpen
Co-produce with usInvestment, In-Kind SupportNo fixed amountOpen